Literature DB >> 10582381

Mental health in the Oregon Health Plan: fragmentation or integration?

D L Cutler1, B H McFarland, K Winthrop.   

Abstract

The Oregon Health Plan was implemented in 1994 with a 50% expansion of Medicaid enrollment to include some of the working poor. Over 75% of Oregon Medicaid clients are now enrolled in health maintenance organizations (HMOs). Outpatient chemical dependency services have been capitated since May 1995. Capitated mental health services have been provided for the 25% of eligibles who live in demonstration counties since January 1995. Expansion and capitation appear to have been achieved without major trauma. More challenging has been the attempted integration of public sector behavioral health services with private sector health plans. Stakeholders interviewed for this study were especially concerned about the long-term impact on Medicaid clients with chronic mental illness. Strong leadership and clear policies regarding the mixture of public, private nonprofit, and private for profit entities are necessary if the state is to achieve its aim of integration without fragmenting a system of care for people with severe mental illness.

Entities:  

Mesh:

Year:  1998        PMID: 10582381     DOI: 10.1023/a:1022249606959

Source DB:  PubMed          Journal:  Adm Policy Ment Health        ISSN: 0894-587X


  3 in total

1.  How managed care has affected mental health case management activities, caseloads, and tenure.

Authors:  Joseph G Hromco; Michael W Moore; Robert E Nikkel
Journal:  Community Ment Health J       Date:  2003-12

2.  Four decades of community mental health: a symphony in four movements.

Authors:  David L Cutler; Joseph Bevilacqua; Bentson H McFarland
Journal:  Community Ment Health J       Date:  2003-10

3.  Outcomes for medicaid clients with substance abuse problems before and after managed care.

Authors:  Bentson H McFarland; Dennis D Deck; Lynn E McCamant; Roy M Gabriel; Douglas A Bigelow
Journal:  J Behav Health Serv Res       Date:  2005 Oct-Dec       Impact factor: 1.505

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.